http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201703771-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc53d78966d00bb9ffa6b615f1a6659e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451 |
| filingDate | 2015-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e4edc675c5a9d48606872281d694c08 |
| publicationDate | 2017-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201703771-A |
| titleOfInvention | Cyproheptadine as a drug for inhibiting liver cancer |
| abstract | The present invention provides a pharmaceutical composition for inhibiting liver cancer, which is capable of significantly inhibiting the growth of liver cancer cells and causing apoptosis of liver cancer cells by using cyproheptadine as a pharmaceutical composition. Cyproheptadine is highly selective for liver cancer cells and can effectively kill liver cancer cells, but does not affect the survival of normal liver cells. |
| priorityDate | 2015-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 278.